Trial Profile
Study of cinacalcet with gallstones in the hemodialysis (HD) patients with secondary hyperparathyroidism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2018
Price :
$35
*
At a glance
- Drugs Cinacalcet (Primary)
- Indications Secondary hyperparathyroidism
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2018 Results published in the Renal Failure
- 26 Sep 2018 New trial record